English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Thermal and X-ray analysis of racemic bupivacaine hydrochloride

MPS-Authors
/persons/resource/persons135493

Dinnebier,  R. E.
Scientific Facility X-Ray Diffraction (Robert E. Dinnebier), Max Planck Institute for Solid State Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Sykula-Zajac, A., Lodyga-Chruscinska, E., Palecz, B., Dinnebier, R. E., Griesser, U. J., & Niederwanger, V. (2011). Thermal and X-ray analysis of racemic bupivacaine hydrochloride. Journal of Thermal Analysis and Calorimetry, 105(3), 1031-1036.


Cite as: https://hdl.handle.net/21.11116/0000-000E-BF5F-2
Abstract
An amide-type local anesthetic drug, bupivacaine hydrochloride (BupiHCl), in the form of racemate is listed in the European and American pharmacopoeias and continues to be used in medicine. Thermal and X-ray analysis of commercial BupiHCl monohydrate was performed by differential scanning calorimetry with thermogravimetry, hot stage microscopy, and X-ray diffraction. Endothermic dehydration occurs at the temperature range of 73-130 A degrees C for DSC-TG 111 (Setaram) and at 83-150 A degrees C for DSC 404 (Netzsch). Both curves at 2 and 10 A degrees C min(-1) clearly reflect phase transformation of anhydrous Form I into II before reaching the melting point. A well-defined exothermic phase transition of BupiHCl was detected at a lower heating rate. Temperature-resolved X-ray diffraction in conjunction with DSC led to determining a similarity between the obtained thermal events. Microscopic investigation also confirmed the above-mentioned transformations.